Epidemiological study of carcinogenesis of thorotrast was made in the following three ways of survey.
1) Prospective study: Of 147 thorotrast patients surveyed, 3 cases of liver cancer (cholangiocareinoma), 2 cases of liver cirrhosis and 1 case of leukemia were found, while, of 1, 678 of non injected cases, 1 case of leukemia, 5 cases of liver cirrhosis and no liver cancer occurred more frequently in the thorotrast group than in controls.
2) Retrospective study: Of 466 liver cancer patients surveyed, 4 or 0.85% had thorotrast shadow in the roentgenogram of the upper abdomen, while, of 1, 938 controls, 1 or 0.07% the thorotrast shadow. Statistically, the thorotrast maintaining rate is higher in liver cancer patients than in contols.
3) Autopsy case study: Of 38 autopsied cases of thorotrast, 21 were primary liver malignancy, which consisted of 4 hepatomas (19%), 14 cholangiocarcinomas (67%) and 3 endotheliomas (14%). As compared with the autopsy cases of Japanese, cholangiocarcinoma and endothelioma are extremely frequent in thorotrast cases with a statistically significant difference.
View full abstract